´Multimodal motor symptoms quantification platform for individualized Parkinson´s disease treatments´ MuSyQ
| Reference number | |
| Coordinator | RISE Acreo AB - RISE Acreo, Göteborg |
| Funding from Vinnova | SEK 3 600 000 |
| Project duration | November 2014 - March 2017 |
| Status | Completed |
Important results from the project
Motor symptoms is common in Parkinson´s patients. The project has developed a multimodal platform consisting of motion sensors, eyetracker, ability via app to answer questions about disease states and to make a spiral and tap test with a finger on a smartphone´s touchscreen. Platform that has learned from medical data derived from two medical studies in the project has resulted in a system capable of estimating motor symptoms and to give a dosage interval in parity with experienced physicians in 68% of cases.
Expected long term effects
One of the main purposes of the project MUSYQ is to objectively describe the symptoms in patients with Parkinson´s disease. The project has resulted in a system capable of estimating a dosage interval of the treating medicine that is in parity with experienced physicians, in 68% of cases. A great success given the size of the project.
Approach and implementation
WP1 - a medical study that has exceeded expectations. We now have a large data base that also can be used in many future projects. WP2 - a workflow for data analysis and signal processing. Most of the tasks in this package have been published and well advanced in the project. WP3 - medical study to test the methods developed in the project. It turned out that 68% of the patients studied were given dosage intervals of the system that were in par with experienced physicians. WP4 - Business Strategy - A patent has been written and will be sent soon.